Marta Munar Bestard received her Bachelor degree (BD) in Biochemistry (2015) at the University of the Balearic Islands (UIB) and her Master of Investigation in Biomedicine (2016) at the University Complutense of Madrid (UCM). From June 2014 to September 2014, she collaborated on the Project “Pseudomonas aeruginosas AmpDh3 amidase, an essential pro-inflammatory virulence factor” at IdISBa within the Microbiology group, and from October 2015 to July 2016, she collaborated on the Project “Intranasal administration of TAT conjugated lipid nanocarriers loading GDNF for Parkinson´s disease” at the Research Institute Hospital 12 de Octubre on Neuroscience (imas12).In January 2019, she has started working at the group “ Cell Therapy and Tissue Engineering ( TERCIT)” at the IUNICS-UIB with PFIS grant (Instituto de Salud Carlos III)( FI18/00104).